Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'bax inhibitor peptide negative control'

Search results for: 'bax inhibitor peptide negative control'

Items 11-20 of 223

Page
per page
  1. Beta-Amyloid (1-11)
    A1002 Beta-Amyloid (1-11)
    Summary: Amyloidogenic peptide
      insoluble in EtOH; ≥132.5 mg/mL
  2. Agouti-related Protein (AGRP) (25-82), human
    A1134 Agouti-related Protein (AGRP) (25-82), human
    Target: Melanocortin (MC) Receptors
    Summary: Agouti-related peptide(25-82)
      insoluble in EtOH; insoluble in DMSO; ≥100 mg/mL
  3. Endomorphin-1
    A1013 Endomorphin-1
    Summary: Agonist of μopioid receptors,highly potent and selective
      ≥14.9 mg/mL
  4. Melanocyte stimulating hormone release inhibiting factor
    A1121 Melanocyte stimulating hormone release inhibiting factor
    Summary: MSH release-inhibiting factor
      ≥59.1 mg/mL
  5. Amyloid β-Protein (1-15)
    A1003 Amyloid β-Protein (1-15)
    Summary: Principal component of amyloid
      insoluble in EtOH; ≥182.6 mg/mL
  6. TC-DAPK 6
    A3862 TC-DAPK 6
    Summary: DAPK inhibitor
      Soluble in DMSO
  7. amyloid A protein fragment [Homo sapiens]
    A1053 amyloid A protein fragment [Homo sapiens]
    Summary: Apolipoproteins related to HDL in plasma
  8. Olcegepant
    A3680 Olcegepant
    Target: CGRP receptors
    Summary: Non-peptide receptor of CGRP,first potent and selective
      ≥87 mg/mL
  9. ADX 10059 hydrochloride
    B5586 ADX 10059 hydrochloride
    Summary: Negative allosteric modulator at mGlu5
      <6.92 mg/mL
  10. Semagacestat (LY450139)
    A8190 Semagacestat (LY450139)
    Summary: γ-secretase inhibitor
      insoluble in H2O; ≥18.05 mg/mL

Items 11-20 of 223

Page
per page
Shop By
Now Shopping by
  1. Category Neuroscience Remove This Item
Clear All
Shopping Options
Category
  1. 5-HT Receptor 25item
  2. AChR 11item
  3. AChE 14item
  4. Alzheimer 15item
  5. Amyloid β 19item
  6. BACE 3item
  7. CGRP 2item
  8. COX 71item
  9. DAPK 1 item
  10. Dopamine Receptor 14item
  11. GABA Receptor 1 item
  12. Gap Junction 6item
  13. GluR 11item
  14. Histamine Receptor 11item
  15. mPEGS-1 4item
  16. Neuroscience Peptides 31item
  17. Nicotinic Receptor 2item
  18. P2 Receptor 1 item
  19. P2X7 receptor 1 item
  20. SSRIs 5item
  21. Substance P/NK1 Receptor 1 item
Specificity
  1. Selective 28item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 2item
Target
  1. Gap Junctions 4item
  2. Voltage-gated Potassium (KV) Channels 1 item
  3. CGRP receptors 1 item
  4. Trk Receptors 1 item
  5. NMDA Receptors 1 item
  6. STAT 1 item
  7. M3 Receptors 1 item
  8. 5-HT2 Receptors 4item
  9. Voltage-gated Calcium Channels (CaV) 1 item
  10. Melanocortin (MC) Receptors 1 item
  11. D2 Receptors 2item
  12. D3 Receptors 1 item
  13. 5-HT1 Receptors 2item
  14. 5-HT7 Receptors 1 item
  15. Serotonin reuptake 1 item
  16. COX 10item
  17. Histamine H1 Receptors 2item
  18. Inositol-requiring enzyme 1 (IRE1) 1 item
  19. Norepinephrine transporter 1 item
  20. 5-HT Transporters 3item
  21. Norepinephrine transporters 1 item
  22. AChE 2item
  23. NMDA receptor 1 item
  24. Na /Ca2 Exchangers (NCXs) 1 item
  25. BACE 2item
  26. Tryptophan hydroxylases (TPH) 1 item
  27. sodium channels 1 item
  28. adrenergic receptor 1 item
  29. 5-HT4 Receptor 1 item
  30. Histamine receptors 1 item
  31. GluR 1 item
  32. 5-HT receptor 1 item
  33. dopamine receptors 1 item
  34. AMPA receptor 1 item
  35. Prostaglandin synthesis 1 item
  36. PAFR 1 item
  37. Serotonin (5-HT) reuptake 1 item
  38. Substance P/NK1 Receptor 1 item
Reported Experiments
  1. Animal Experiments 40item
  2. Cell Experiments 36item
Related Disease
  1. Acute Kidney Injury 1 item
  2. Bladder Diseases 1 item
  3. Brain Injuries Studies 1 item
  4. Breast Cancer 1 item
  5. Cancer 5item
  6. Colon Cancer 1 item
  7. Colorectal Cancer 1 item
  8. Depression 2item
  9. HIV Infections 1 item
  10. Inflammatory Diseases 1 item
  11. Kidney Injury Studies 1 item
  12. Leukemia 1 item
  13. Lymphoma 1 item
  14. Multiple Myeloma 1 item
  15. Pancreatic Cancer 1 item
  16. Prostate Cancer 1 item
  17. Schizophrenia 4item